Palforzia is now approved for use in individuals aged 4 through 17 who have a confirmed diagnosis of peanut allergy.
First Peanut Allergy Drug Gets FDA Thumbs Up
Palforzia is now approved for use in individuals aged 4 through 17 who have a confirmed diagnosis of peanut allergy.